Interactive Brokers senior market analyst Steven Levine discusses consumer sentiment with Greenwich Wealth Management CIO Vahan Janjigian.
Levine also provides some highlights for what to look for in the United States in mid-January.
Photo Credit: Dushan Hanuska via Flickr Creative Commons
Investors in pharmaceutical companies need to navigate the nuances of the drug discovery process, including FDA designations, patent cliffs, and generic competition to make informed investment decisions.
The markets were caught off guard by the new AI startup based in China – but was it a “black swan” event or just another development in the fast-moving world of AI?
The Federal Reserve will have to wait even longer for evidence confirming that gains in fighting price pressures are durable before it turns accommodative with this morning’s data showing higher-than-anticipated inflation.
The Fed’s QE3 announcement is welcome by a lot of people on the Street, but not many retirees on Main Street.
